Christopher Hansen

Christopher Hansen

Auto-generated profile, based on publicly available information

Christopher Hansen

Medical College of Wisconsin, Department of Biomedical Engineering, Milwaukee, Wisconsin, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
APAbdul Kareem Parchur
Abdul Kareem Parchur
ZFZhi Fang
Zhi Fang
JJJaidip M Jagtap
Jaidip M Jagtap
GSGayatri Sharma
Gayatri Sharma
CHChristopher Hansen
Christopher Hansen
AJAmit Joshi
Amit Joshi
Left panel: Pseudocolor map of 3 principle components from NIR-II kinetic imaging, Right panel (top to bottom): In vivo Ag 2 S QD NIR-II fluorescence, ex vivo iodine micro-CT, FITC dextran perfusion, and H&E staining in control vs CCM1+/− mice brain.

10 June 2024 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
ASAustin Stellpflug
Austin Stellpflug
JWJacob Walls
Jacob Walls
CHChristopher Hansen
Christopher Hansen
AJAmit Joshi
Amit Joshi
BWBo Wang
Bo Wang
This study developed a new type of bone-based nanoparticle (BPs) directly from the entire decellularized porcine bone, additionally encapsulating indocyanine green dye (ICG) for an in vivo monitoring capability.

1 January 2023 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
GSGayatri Sharma
Gayatri Sharma
MKMir Hadi Razeghi Kondelaji
Mir Hadi Razeghi Kondelaji
GSGuru P. Sharma
Guru P. Sharma
CHChristopher Hansen
Christopher Hansen
APAbdul Kareem Parchur
Abdul Kareem Parchur
AJAmit Joshi
Amit Joshi
Introduction: Radiation therapy for head and neck squamous cell carcinoma is constrained by radiotoxicity to normal tissue. We demonstrate 100 nm theranostic nanoparticles for image-guided radiation therapy planning and enhancement in rat head and neck squamous cell carcinoma models. Methods: PEG conjugated theranostic nanoparticles comprising of Au nanorods coated with Gadolinium oxide layers were tested for radiation therapy enhancement in 2D cultures of OSC-19-GFP-luc cells, and orthotopic tongue xenografts in male immunocompromised Salt sensitive or SS rats via both intratumoral and intravenous delivery. The radiation therapy enhancement mechanism was investigated. Results: Theranostic nanoparticles demonstrated both X-ray/magnetic resonance contrast in a dose-dependent manner. Magnetic resonance images depicted optimal tumor-to-background uptake at 4 h post injection. Theranostic nanoparticle + Radiation treated rats experienced reduced tumor growth compared to controls, and reduction in lung metastasis. Conclusions: Theranostic nanoparticles enable preprocedure radiotherapy planning, as well as enhance radiation treatment efficacy for head and neck tumors.

1 October 2023
Verified
Book Chapter
Closed access
PDF file
MZMykhaylo Zayats
Mykhaylo Zayats
CHChristopher Hansen
Christopher Hansen
Ronan CahillRonan Cahill
Ronan Cahill
GGGareth Gallagher
Gareth Gallagher
Ra'ed MalallahRa'ed Malallah
Ra'ed Malallah
SZSergiy Zhuk
Sergiy Zhuk

26 September 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
CHChristopher Hansen
Christopher Hansen
JJJaidip M Jagtap
Jaidip M Jagtap
APAbdul Kareem Parchur
Abdul Kareem Parchur
GSGayatri Sharma
Gayatri Sharma
SSShayan Shafiee
Shayan Shafiee
AJAmit Joshi
Amit Joshi
SignificanceAlthough the lymphatic system is the second largest circulatory system in the body, there are limited techniques available for characterizing lymphatic vessel function. We report shortwave-infrared (SWIR) imaging for minimally invasive in vivo quantification of lymphatic circulation with superior contrast and resolution compared with near-infrared first window imaging.AimWe aim to study the lymphatic structure and function in vivo via SWIR fluorescence imaging.ApproachWe evaluated subsurface lymphatic circulation in healthy, adult immunocompromised salt-sensitive Sprague–Dawley rats using two fluorescence imaging modalities: near-infrared first window (NIR-I, 700 to 900 nm) and SWIR (900 to 1800 nm) imaging. We also compared two fluorescent imaging probes: indocyanine green (ICG) and silver sulfide quantum dots (QDs) as SWIR lymphatic contrast agents following intradermal footpad delivery in these rats.ResultsSWIR imaging exhibits reduced scattering and autofluorescence background relative to NIR-I imaging. SWIR imaging with ICG provides 1.7 times better resolution and sensitivity than NIR-I, and SWIR imaging with QDs provides nearly two times better resolution and sensitivity with enhanced vessel distinguishability. SWIR images thus provide a more accurate estimation of in vivo vessel size than conventional NIR-I images.ConclusionsSWIR imaging of silver sulfide QDs into the intradermal footpad injection provides superior image resolution compared with conventional imaging techniques using NIR-I imaging with ICG dye.